Sangrix Inc. (SGRX) Key Metrics
SGRX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.7M
- Enterprise value
- $10.4M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 8.8
- Price / book
- 0.1
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 2.01
SGRX key metrics, FY2017–FY2026
Fiscal year ended June 30, 2026 · U.S. dollarsSGRX returns How much profit the business earns on the capital it uses.
SGRX financial health Debt, liquidity and how easily interest is covered.
SGRX valuation history
SGRX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SGRX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SGRX price vs earnings per share
SGRX key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $4.7M | — | — | — | — | — | — | — | — | — |
| Enterprise value | $13.7M | — | — | — | — | — | — | — | — | — |
| Price / book | 0.5 | — | — | — | — | — | — | — | — | — |
| Earnings yield | −306.0% | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | −62.6% | — | — | — | — | — | — | — | — | — |
| Dividend yield | 0.0% | — | — | — | — | — | — | — | — | — |
| Shareholder yield (dividends + buybacks) | 0.0% | — | — | — | — | — | — | — | — | — |
| Share price at fiscal year-end | $6.25 | $47.40 | $864.00 | $613.05 | $3,914.10 | $14,130.00 | $11,700.00 | — | — | — |
| Per share | ||||||||||
| Revenue per share | $0.00 | — | — | — | — | — | — | — | — | — |
| Earnings per share | −$19.12 | — | — | — | — | — | — | — | — | — |
| Operating cash flow per share | −$3.91 | — | — | — | — | — | — | — | — | — |
| Free cash flow per share | −$3.91 | — | — | — | — | — | — | — | — | — |
| Cash per share | $2.10 | — | — | — | — | — | — | — | — | — |
| Book value per share | $13.15 | — | — | — | — | — | — | — | — | — |
| Tangible book value per share | $13.15 | — | — | — | — | — | — | — | — | — |
| Dividends per share | $0.00 | — | — | — | — | — | — | — | — | — |
| Capex per share | $0.00 | — | — | — | — | — | — | — | — | — |
| Debt per share | $14.22 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 747K | — | — | — | — | — | — | — | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −208.2% | −157.7% | −294.1% | −125.6% | 20.6% | — | −20.2% | 21.6% | 29.0% | 27.8% |
| Return on invested capital (ROIC) | −23.4% | −52.0% | −151.5% | −100.0% | −29.4% | — | −6.7% | 20.0% | 19.4% | 14.5% |
| Return on assets (ROA) | −115.7% | −85.8% | −175.1% | −116.9% | 8.5% | −87.5% | −8.5% | 10.3% | 12.4% | 11.6% |
| Return on tangible assets | −67.5% | −124.1% | −262.3% | −211.6% | 9.3% | −111.6% | −8.4% | 8.6% | 11.3% | 9.3% |
| Free cash flow margin | — | — | −274.5% | −109.8% | — | — | −24.4% | −5.3% | −3.6% | −4.0% |
| Income quality (OCF / net income) | — | — | — | — | −4.39 | — | — | −1.21 | −0.95 | −1.02 |
| Financial health | ||||||||||
| Total debt | $10.6M | — | $5.2M | $2.1M | — | $1.3M | $6.5M | $10.9M | $10.4M | $11.9M |
| Cash & short-term investments | $1.6M | $55,639 | $1.6M | $2.1M | $159,693 | $1,943 | $1.1M | $3.2M | $319,093 | $21,530 |
| Net debt | $9.1M | −$55,639 | $3.6M | −$24,805 | −$159,693 | $1.3M | $5.4M | $7.7M | $10.1M | $11.9M |
| Debt / equity | 1.08 | — | 3.11 | 0.20 | — | — | 0.27 | 0.45 | 0.66 | 1.17 |
| Debt / assets | 0.50 | — | 0.77 | 0.16 | — | 0.03 | 0.10 | 0.21 | 0.31 | 0.44 |
| Net debt / EBITDA | — | — | — | — | — | — | — | 1.17 | 1.66 | 2.92 |
| Current ratio | 6.98 | 9.50 | 2.68 | 1.38 | 19.18 | 0.84 | 1.54 | 2.00 | 1.72 | 1.31 |
| Quick ratio | 6.98 | 9.50 | 2.68 | 1.38 | 19.18 | 0.83 | 1.54 | 2.00 | 1.72 | 1.29 |
| Interest coverage | — | -6.6 | -29.8 | -124.5 | -111.9 | -22.3 | -4.9 | 7.2 | 4.3 | 5.3 |
| Working capital | $8.7M | $3.2M | $4.2M | $984,500 | $5.5M | −$6.2M | $17.5M | $22.9M | $12.1M | $5.2M |
| Invested capital | $18.9M | $3.8M | $5.2M | $10.2M | $34.5M | −$1.9M | $29.2M | $32.3M | $25.9M | $22.0M |
| Tangible asset value | $9.1M | $3.2M | $909,583 | $10.3M | $34.7M | −$1.6M | $21.6M | $24.1M | $15.3M | $9.6M |
| Net current asset value | −$1.9M | $3.2M | $909,583 | $498,168 | $5.5M | −$10.0M | $13.8M | $18.9M | $11.1M | $5.2M |
| Graham net-net per share | −$14.07 | — | — | — | — | — | — | — | — | — |
| Capital allocation | ||||||||||
| Dividends paid | $0 | — | $0 | $0 | $0 | — | — | — | — | — |
| Dividend payout ratio | — | — | — | — | 0.0% | — | — | — | — | — |
| Capex / revenue | — | 0.0% | 0.0% | 1.8% | 4,316.5% | — | 0.0% | 0.0% | 0.1% | 0.0% |
| Capex / depreciation | — | — | 0.00 | 0.02 | 30.00 | — | 0.00 | 0.04 | 0.16 | 0.02 |
| Stock-based compensation / revenue | — | — | 2.5% | 1.1% | 843.3% | — | — | — | — | — |
| SG&A / revenue | — | — | 134.7% | 47.6% | 3,039.9% | — | — | — | — | — |
| Efficiency | ||||||||||
| Days sales outstanding | — | 36,973.5 | 350.3 | 142.5 | 14,766.3 | — | 373.6 | 122.8 | 83.3 | 73.5 |
| Days of inventory on hand | — | — | — | — | — | — | — | — | 0.6 | 4.5 |
| Days payables outstanding | — | — | 31.8 | 11.3 | 4,508.9 | — | 118.1 | 23.4 | 11.5 | 10.0 |
| Cash conversion cycle (days) | — | — | 318.5 | 131.2 | 10,257.4 | — | 255.4 | 99.4 | 72.4 | 68.0 |
| Receivables turnover | — | 0.01 | 1.04 | 2.56 | 0.02 | 0.00 | 0.98 | 2.97 | 4.38 | 4.96 |
| Payables turnover | — | — | 11.48 | 32.42 | 0.08 | — | 3.09 | 15.60 | 31.82 | 36.40 |
| Inventory turnover | — | — | — | — | — | — | — | — | 641.32 | 81.91 |
| Asset turnover | 0.00 | 0.01 | 0.29 | 0.26 | 0.01 | 0.00 | 0.42 | 2.33 | 3.33 | 2.98 |
| Average receivables | — | $4.0M | $2.8M | $2.4M | $7.8M | $10.5M | $24.8M | $33.3M | $23.1M | $12.7M |
| Average payables | — | — | $333,956 | $333,956 | $5.0M | $7.8M | $7.2M | $5.8M | $2.9M | $1.6M |
| Average inventory | — | — | — | — | — | $229,392 | — | — | $142,601 | $710,638 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 8.2% | 0.9% | 1.5% | 1.8% |
Computed from SGRX's annual financial statements (latest annual report filed —) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SGRX valuation and financial ratios
Sangrix earned a return on equity of −208.2% and a return on invested capital of −23.4% in fiscal 2026. It ended the year with $10.6 million of debt and $1.6 million in cash and short-term investments, net debt of $9.1 million.
See the SGRX income statement, the SGRX chart for price history, or the SGRX stock overview for the latest quote and news.
SGRX key metrics FAQ
What is Sangrix's return on equity?
Sangrix's return on equity (ROE) was −208.2% in fiscal 2026: net income of -$14.3 million on average shareholders' equity of $6.9 million.
What is Sangrix's ROIC?
Sangrix's return on invested capital was −23.4% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Sangrix have?
Sangrix had total debt of $10.6 million at the end of fiscal 2026, a debt-to-equity ratio of 1.08.
Does Sangrix pay a dividend?
Sangrix did not pay a dividend in fiscal 2026.
What is Sangrix's free cash flow yield?
Sangrix generated -$2.9 million of free cash flow in fiscal 2026, a free cash flow yield of −62.6% on its market value at year-end ($4.7 million).
What is Sangrix's current ratio?
Sangrix's current ratio was 6.98 at the end of fiscal 2026: current assets were 6.98 times current liabilities.